Venous thromboembolism prophylaxis audit in two Queensland hospitals

Phillips, N. M. and Heazlewood, V. J. (2013) Venous thromboembolism prophylaxis audit in two Queensland hospitals. Internal Medicine Journal, 43 5: 560-566. doi:10.1111/imj.12033

Author Phillips, N. M.
Heazlewood, V. J.
Title Venous thromboembolism prophylaxis audit in two Queensland hospitals
Journal name Internal Medicine Journal   Check publisher's open access policy
ISSN 1444-0903
Publication date 2013-05
Year available 2013
Sub-type Article (original research)
DOI 10.1111/imj.12033
Open Access Status
Volume 43
Issue 5
Start page 560
End page 566
Total pages 7
Place of publication Richmond, VIC, Australia
Publisher Wiley-Blackwell
Collection year 2014
Language eng
Formatted abstract
Venous thromboembolism (VTE) represents a major public health problem in Australia and worldwide, contributing to hundreds of thousands of deaths each year.

To assess adherence to recommended guidelines in a range of clinical settings.

Retrospective, observational study of 955 medical (M), surgical (S) and orthopaedic (O) patient charts of all M, S and O patients admitted during March 2011. Patients on warfarin were excluded from the analysis. Appropriate or inappropriate prophylaxis was assessed according to high, medium and low risk stratification. Patient risk stratification for VTE, suitability of prophylaxis given, adverse events and length of stay were recorded.

Nine hundred and thirteen eligible patients were assessed, 54% male, mean age 57 ± 21 years. Regarding the 372 M patients, 235 (63%) were on appropriate prophylaxis, compared with 84% (273/326) S and 78% (168/215) O patients (M to S, P < 0.0001; M to O, P = 0.0002; S to O, P = 0.113). High risk prevalence was 56% in M, 9% in S and 12% in O patients (P < 0.0001). Nine confirmed or possible VTE events occurred (seven M, with five of these on inappropriate prophylaxis). All three bleeding events (one fatal) were in M patients, two of whom had appropriate prophylaxis. Average length of stay was 4.1 ± 5.0, 2.1 ± 3.3 and 2.1 ± 3.8 days (P < 0.001) for M, S and O patients respectively.

Better adherence to prophylaxis guidelines is required, especially in M patients where the prevalence of high-risk VTE is greater.
Keyword Venous thromboembolism
Deep vein thrombosis
Pulmonary embolism
Clinical audit
Q-Index Code C1
Q-Index Status Confirmed Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Official 2014 Collection
School of Medicine Publications
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 2 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 2 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Sun, 30 Jun 2013, 00:18:18 EST by System User on behalf of School of Medicine